Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pancreatic cancer through laboratory testing and whose doctors have determined they need combination immunotherapy based on clinical guidelines
- People who have signed and dated a consent form agreeing to take part in the trial
- People who are willing and able to follow all study procedures and take part in the full research process
- People between 18 and 75 years old
- People who are in reasonably good general health and are expected to live for more than 6 months
Who may not be able to join:
- People with serious illnesses that the trial researchers consider too risky for participation, such as severe heart or lung failure, severely reduced bone marrow function, or serious liver or kidney problems
- People who have a hole in their intestine (intestinal perforation) or a complete blockage of the intestine
- People who are pregnant, may be pregnant, or are currently breastfeeding
- People who are unlikely to be able to follow the study rules and requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13524945287
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation the responses to immunotherapy of pancreatic cancer; Standardized uptake value(SUV); Target-to-background ratio(TBR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.